Visual event-related potentials in cirrhotic patients without overt encephalopathy: The effects of flumazenil

Metabolic Brain Disease

Volumn 16, Issue 1-2, 2001, Pages 43-53

  Jones, E Anthony ^a   Giger Mateeva, Vessela I ^a   Reits, Dick ^a   Riemslag, Frans C C ^a   Liberov, Boris ^a   Spekrijse, Henk ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cirrhosis; Event related evoked potentials; Flumazenil; Subclinical hepatic encephalopathy

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; FLUMAZENIL; PLACEBO;

ADULT; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EVOKED VISUAL RESPONSE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; VISUAL STIMULATION;

ADULT; AROUSAL; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, VISUAL; FLUMAZENIL; GABA MODULATORS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; PSYCHOMETRICS;

EID: 0035165598     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011662411913     Document Type: Article

References (19)

1. The pathogenesis and treatment of hepatic encephalopathy; Evidence for the involvement of benzodiazepine receptor ligands
2. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy
3. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil
4. Newer approaches to therapy of hepatic encephalopathy
5. Isolation of the late event-related components to checkerboard stimulation
6. The effects of flumazenil on visual event-related potentials in clinically non-encephalopathic patients with cirrhosis
7. Visual event-related potentials in cirrhotic patients without overt encephalopathy
8. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, non-shunted patients with cirrhosis
9. Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy
10. Does ammonia contribute to increased GABAergic neurotransmission in liver failure?
11. Flumazenil: Potential implications for hepatic encephalopathy
12. Visual event-related P300 potentials in early portosystemic encephalopathy
13. Subclinical hepatic encephalopathy: The diagnostic value of evoked potentials
14. Natural benzodiazepines and hepatic encephalopathy
15. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neurophysiological tests and automated electroencephalogram analysis
16. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice
17. The pattern flash elicited P300-complex (PF-300): A new method for studying cognitive processes of the brain
18. Objective measurement of hepatic encephalopathy by means of automated EEG analysis
19. Interindividual variability of the number connection test